dyanavel xr 5 Drug Patent Profile
✉ Email this page to a colleague
When do Dyanavel Xr 5 patents expire, and what generic alternatives are available?
Dyanavel Xr 5 is a drug marketed by Tris Pharma Inc and is included in one NDA. There are four patents protecting this drug.
This drug has twenty-one patent family members in fourteen countries.
The generic ingredient in DYANAVEL XR 5 is amphetamine; amphetamine aspartate/dextroamphetamine sulfate. There are fifty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amphetamine; amphetamine aspartate/dextroamphetamine sulfate profile page.
DrugPatentWatch® Generic Entry Outlook for Dyanavel Xr 5
Indicators of Generic Entry
Summary for dyanavel xr 5
International Patents: | 21 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | dyanavel xr 5 at DailyMed |
Recent Clinical Trials for dyanavel xr 5
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Tris Pharma, Inc. | Phase 4 |
Tris Pharma, Inc. | Phase 3 |
Pharmacology for dyanavel xr 5
Drug Class | Central Nervous System Stimulant |
Physiological Effect | Central Nervous System Stimulation |
US Patents and Regulatory Information for dyanavel xr 5
dyanavel xr 5 is protected by four US patents.
Patents protecting dyanavel xr 5
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER
Modified release formulations containing drug-ion exchange resin complexes
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Modified release formulations containing drug-ion exchange resin complexes
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Modified release formulations containing drug-ion exchange resin complexes
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
International Patents for dyanavel xr 5
See the table below for patents covering dyanavel xr 5 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Korea | 20080108520 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG - ION EXCHANGE RESIN COMPLEXES | ⤷ Try a Trial |
Spain | 2378573 | ⤷ Try a Trial | |
Austria | E536867 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 2007109104 | ⤷ Try a Trial | |
Denmark | 2018160 | ⤷ Try a Trial | |
Taiwan | 200812649 | Modified release formulations containing drug-ion exchange resin complexes | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |